Masimo stock soars on strong Q4 results, positive outlook

Masimo Reports Strong Q4 Results and Raises Revenue Forecast for 2024

Masimo, a leading medical technology company, has reported strong preliminary results for the fourth quarter of this year. The company expects its revenue for the quarter to be in the range of $541 million to $551 million, surpassing the Street’s estimate of $537 million. This positive performance reflects the continued demand for Masimo’s innovative products and solutions in the healthcare industry.